Riverstone Holdings Limited reported a net profit of 52.0 million Malaysian ringgit (RM) for the three months ended 30 September 2025, down 28.0% year-on-year but 14.7% higher than the preceding quarter, supported by firmer demand for its cleanroom consumables from data-centre and artificial-intelligence (AI) customers.

Diluted earnings per share stood at 3.51 sen, compared with 4.87 sen a year earlier. The board declared a third interim dividend of 2.5 sen per share, lifting the year-to-date payout ratio to 77.1%. No comparative dividend figure for the prior-year quarter was provided.

Quarterly revenue slipped 17.1% YoY to RM247.5 million, weighed by lower average selling prices in the healthcare-glove segment, although sales in the cleanroom and customised healthcare categories improved. Profit before tax came in at RM67.2 million, down 25.6% YoY. Gross profit fell 26.1% YoY to RM76.6 million; however, gross margin recovered to 30.9% from 26.8% in 2QFY25 thanks to a more favourable product mix and lower raw-material costs.

Demand from semiconductor, electronics and data-storage clients underpinned a 1.1% sequential rise in overall revenue and a 16.5% quarter-on-quarter rebound in gross profit. Lower raw-material prices and gains from the disposal of property, plant and equipment also helped offset adverse foreign-exchange movements, limiting operating expenses to RM0.8 million versus RM6.6 million a year earlier.

Management said Riverstone’s newly commissioned cleanroom production lines are ready to accommodate accelerating orders tied to global AI infrastructure investment. At the same time, executives acknowledged that generic healthcare-glove pricing remains under pressure amid intense industry competition; consequently, the group plans to focus on higher-value customised products to defend margins and support long-term growth.

Cash flow from operations reached RM46.0 million during the quarter, leaving cash and cash equivalents at RM660.9 million as of end-September. The company did not disclose new quantitative earnings guidance but highlighted ongoing capacity expansions and product-mix optimisation as key strategic priorities in the current demand environment.